BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
CHMP recommends approval of TOBI Podhaler for cystic fibrosis
Sep. 28, 2010
CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML
Sep. 28, 2010
FDA and EMA to review vandetanib for advanced medullary thyroid cancer
Sep. 27, 2010
EMA updates nevirapine label for patients with HIV-1 infection
Sep. 21, 2010
Novartis Europharm withdraws Rasival MAA for essential hypertension
Sep. 21, 2010
GSK investigates reports of narcolepsy following Pandemrix vaccination
Sep. 6, 2010
MSD's Sycrest approved in Europe for biopolar disorder
Sep. 3, 2010
FDA approves Bionovo's CMC plan for Menerba
Aug. 31, 2010
EMA investigates potential relationship between Pandemrix and narcolepsy
Aug. 30, 2010
European Commission updates license for Cervarix HPV vaccine
Aug. 30, 2010
Previous
1
2
…
138
139
140
141
142
143
144
145
146
…
158
159
Next
RSS